Biocompatables To Pay $36M To Settle Justice Investigation Into LC Bead Device

Mealey's (October 12, 2016, 9:30 AM EDT) -- LONDON — BTG PLC on Oct. 6 announced that its Biocompatables Inc. subsidiary has agreed to pay $36 million to settle a U.S. Justice Department investigation into the marketing of its LC Bead anti-tumor device.

In a press release, BTG said the $36 million settles all allegations.  It said the settlement does not require it to enter into a corporate integrity agreement.

It also noted that the investigation focused on activities that predated BTG’s acquisition of Biocombatibles in 2011.  BTG said it disclosed the investigation in...
To view the full article, register now.